Skip to content
Longterm Wiki
Back

Credibility Rating

4/5
High(4)

High quality. Established institution or organization with editorial oversight and accountability.

Rating inherited from publication venue: Nuclear Threat Initiative

This is a biographical profile page for a public health and biosecurity expert; relevant as background on a key figure in biodefense and pandemic preparedness policy, but not directly focused on AI safety topics.

Metadata

Importance: 18/100homepage

Summary

Profile of Margaret Hamburg, a prominent public health administrator and physician who served as FDA Commissioner, NTI senior fellow, and holds leadership roles in global science and health policy organizations. Her career spans biodefense, pandemic preparedness, and biological threat reduction, making her relevant to biosecurity and existential risk discussions.

Key Points

  • Served as FDA Commissioner (21st) overseeing food safety modernization, medical product innovation, and tobacco regulation
  • Worked at Nuclear Threat Initiative 2001-2009 as advocate for public health infrastructure to counter bioterrorism and pandemics
  • Currently co-president of InterAcademy Partnership, advising on scientific, technological, and health issues globally
  • Initiated New York City's first public health biological threat defense program and worked on tuberculosis containment in the 1990s
  • Serves on President's Intelligence Advisory Board, bridging public health expertise with national security policy

Cited by 1 page

Cached Content Preview

HTTP 200Fetched Mar 20, 20263 KB
[Close](https://www.nti.org/about/people/margaret-hamburg-md/)

![](https://www.nti.org/wp-content/uploads/2021/09/Peggy_Hamburg_Thumbnail.png)

# Margaret   Hamburg, M.D.

Co-president, InterAcademy Partnership

[Download Photo](https://www.nti.org/wp-content/uploads/2021/09/Margaret_Hamburg.jpg)

## Bio

Margaret “Peggy” Hamburg is an American physician and public health administrator who currently serves as co-president of the InterAcademy Partnership (IAP), the global network of science, engineering and medical academies working together to provide independent expert advice on scientific, technological and health issues. She is also vice chair of the President’s Intelligence Advisory Board. She previously served as foreign secretary of the National Academy of Medicine, the health arm of the National Academy of Sciences, after serving for six years as the commissioner of the U.S. Food and Drug Administration. Hamburg also served as president and chair of the board of the American Association for the Advancement of Science from 2017-2019. From 2001-2009, she worked for the Nuclear Threat Initiative, where she became a leading advocate for changes in the nation’s public health policies and infrastructure to meet the challenges presented by biological threats including pandemics and bioterrorism. In 1997, President Bill Clinton named Hamburg assistant secretary for planning and evaluation in the Department of Health and Human Services. Previously, Hamburg served as commissioner of the New York City Department of Health and Mental Hygiene from 1991-1997. There, she focused on improved services for women and children, promoted needle-exchange programs to reduce the spread of HIV, initiated the nation’s first public health biological threat defense program, and, in particular, worked on curbing the resurgence and spread of tuberculosis.

Hamburg was the 21st Commissioner of the Food and Drug Administration and the second woman to serve in the position. During her tenure, she oversaw the modernization of the food safety system to reduce foodborne illness; the advancement of regulatory science, including biomedical product innovation by modernizing and streamlining systems for review and approval of novel medical products in cutting-edge areas of science and medicine; the securing of a safer globalized food and medical product supply chain; and implementation of the Family Smoking Prevention and Tobacco Control Act to reduce the death and disease caused by tobacco.

Hamburg is a graduate of Harvard College and Harvard Medical School. She conducted research on neuroscience at Rockefeller University, studied neuropharmacology at the National Institute of Mental Health, and undertook HIV/AIDS policy and research as assistant director of the National Institute of Allergy and Infectious Diseases.

[Close](https://www.nti.org/about/people/margaret-hamburg-md/)

## My Resources

Send saved resources to:

Send

Remove

### Subscribe to NTI

Sign up for regula

... (truncated, 3 KB total)
Resource ID: 6b51dea9f38fca64 | Stable ID: MzJiMjM1Mj